February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.
October 6, 2022
U.S. News & World Report highlighted recent research from the University of Cincinnati that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
September 21, 2023
The University of Cincinnati's Joseph Broderick, MD, recently joined the Know Stroke Podcast to discuss the current state of stroke research, including the FASTEST trial he is leading to test a potential treatment for strokes caused by ruptured blood vessels in the brain.
September 22, 2023
Drugs.com and HealthDay highlighted University of Cincinnati research recently published in JAMA that found using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal.
February 10, 2023
The University of Cincinnati's Eva Mistry presented research that found using medications to lower systolic blood pressure immediately after mechanical clot removal for acute ischemic stroke may not be safe or effective at the International Stroke Conference 2023.
November 15, 2023
Clinical Research News highlighted recommendations to improve recruitment in acute stroke trials, led by UC's Joseph Broderick, following the Stroke Treatment Academic Industry Roundtable XII earlier this year.
December 8, 2023
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.
May 9, 2024
Memphis, Tennessee television station Action News 5 featured research from the University of Cincinnati's Laura Ngwenya and Jed Hartings that is testing the first treatments for spreading depolarizations, abnormal brain activity also called a "brain tsunami."
May 22, 2024
TCT MD included comments from the University of Cincinnati's Eva Mistry in a story recapping trial data presented at the European Stroke Organisation Conference that found clot-busting drug tenectaplase is becoming a first-choice treatment in certain situations.
May 15, 2023
University of Cincinnati’s Melanie Thomas-Castillo, PsyD, and Stephen Rush, MD, recently published commentary on how psychiatrists can work to create a supportive environment for transgender and gender diverse patients in the journal Current Psychiatry.